The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
"The SP has been clearly weighed down by the selling of Heights - a source of funding which some commentators refer to as 'death spiral' funding."
Strange, as my recollection, was that the Heights funding was almost universal acclaimed on this forum.
Can any body please explain why the Share Trade information on here is so different to that shown on the Summary page of Yahoo for Avacta?
For example, there is a trade on here at 16:20:05 for 211 shares where the price paid is 138.095. At the time, the Bid price is 136 and the Offer price is 139, therefore the trade is shown as a Buy.
However on the Avacta Summary Graph, that trade is shown in red, indicating it is a Sell.
This is just one example but it happens countless times for all trade sizes. Does this mean that none of these boards has the slightest idea whether a trade is a buy or a sell?
"Rampers it has to go through a phase 3 trial with thousands of patients before it will be licensed."
Not true. See following from Cancer Research UK
"Trials covering more than one phase
Most trials are just one phase. But some trials cover more than one phase. For example, the same trial can include both phase 1 and phase 2. So you may see trials written as phase 1/2 or phase 2/3."
I should add that those returns for Pfizer are over a 33 year period and the biggest annual increase was 112% so I don't really have a clue by how much Avacta would increase in the event of AV6000 being a compete success although I would certainly expect the company to be bought.
SNewby also hasn't considered Pfizer share splits which since 1985 have reduced the current price by approximately 25 times but increased the holdings by 25 times! When comparing prices from 1985, the current price should be multiplied by 25 to compare against the 1985 price i.e. a change from 0.60 cents to around $1000!
Exactly and also terrible week for most biotechs in the USA. Very strong performance by Avacta completely against the current tide. Unfortunately, that tide will not turn until interest rates in the world come down.
HL have to issue warnings otherwise when people buy risky shares and they bomb some of them immediately blame the broker for not warning them of the risk! I got the same warning from HL as Avacta is the only share I own and it is risky but I understand I could lose all my money. You take a great risk if you own any single share let alone a small biotech company.
Agreed, and so it should if you compare the pipelines of the 2 companies, but on the face of it it should be flying but biotechs are in the doldrums and have been for a couple of years (since I started buying a few, in fact!). The only ones going up are those getting takeover bids and they are few and far between. The market doesn't like Growth stocks, particularly risky ones, and that shows no sign of changing with the economy in the doldrums and interest rates still going up.